-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 StbLcRjnnAdbOABvKWBm/avX+kg9BZq+GKubOVdBseb6g8aryLa4XA7xkVRPjYzQ
 ACy7MO0+o8GcS1gwZqiLvQ==

<SEC-DOCUMENT>0001104659-11-000679.txt : 20110106
<SEC-HEADER>0001104659-11-000679.hdr.sgml : 20110106
<ACCEPTANCE-DATETIME>20110106171909
ACCESSION NUMBER:		0001104659-11-000679
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20101230
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20110106
DATE AS OF CHANGE:		20110106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		11514977

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a11-1932_18k.htm
<DESCRIPTION>8-K
<TEXT>


<html>
<head>


  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C. 20549</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;8-K</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT REPORT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Pursuant to Section&nbsp;13 or 15(d)&nbsp;of the Securities Exchange Act of 1934</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (Date of earliest event reported): <b>December&nbsp;30, 2010</b></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">BIO-key International,&nbsp;Inc.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as specified in its charter)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or other jurisdiction of<br> incorporation)</font></p>  </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>  </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1-13463</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission File Number)</font></p>  </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>  </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">41-1741861</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(I.R.S. Employer Identification No.)</font></p>  </td>  </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">3349 Highway 138, Building D, Suite&nbsp;B</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Wall, NJ 07719</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal executive offices)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(732)&nbsp;359-1100</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant&#146;s telephone number, including area code)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see</i> General Instruction A.2 below):</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under Exchange Act (17 CFR 240.13e-4(c))</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106200\11-1932-1\task4420356\1932-1-ba.htm',USER='106200',CD='Jan  7 02:19 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 1.01</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Entry into a Material Definitive Agreement</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Effective as of December&nbsp;30, 2010, BIO-key International,&nbsp;Inc. (the &#147;Company&#148;) entered into an Amendment and Waiver agreement (the &#147;Amendment and Waiver&#148;) with respect to the Guaranteed Secured Promissory Note (the &#147;Buyer Note&#148;) that it received from InterAct911 Mobile Systems,&nbsp;Inc. (the &#147;Buyer&#148;), a wholly-owned subsidiary of InterAct911 Corporation (the &#147;Parent&#148;), in the original principal amount of $4 million on Decem
ber&nbsp;8, 2009 in connection with the sale of the Company&#146;s Law Enforcement division to the Buyer.&#160; Under the original terms of the Buyer Note, the initial scheduled repayment of principal, equal to $1.334 million, was due to be paid to the Company on December&nbsp;8, 2010.&#160; Pursuant to the Amendment and Waiver, the Company agreed to defer $834,000 of this initial payment into three equal payments due over the course of the first three quarters of 2011.&nbsp; In exchange for this deferral, the Buyer made a cash principal payment of $500,000, agreed to increase the interest rate on the deferred amount from six percent to twelve percent, and agreed to have the owner of the Parent, Silkroad Equity LLC, forfeit all of the 8 million warrants previously granted to it by the Company.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Effective as of December&nbsp;31, 2010, the Company entered into a Securities Exchange Agreement (the &#147;Exchange Agreement&#148;) with The Shaar Fund,&nbsp;Ltd. (&#147;Shaar&#148;) and Thomas J. Colatosti.&#160; Pursuant to the Exchange Agreement, Shaar exchanged all of its outstanding shares of the Company&#146;s Series&nbsp;D Convertible Preferred Stock, including all accrued and unpaid dividends thereon, and the 7% Convertible Promissory Note dated as of December&nbsp;28, 2009 issued by the Co
mpany to Shaar in the original principal amount of $673,079 for a new non-convertible 7% Secured Promissory Note in the original principal amount of $3,157,759 (the &#147;Shaar Note&#148;).&#160; Shaar also exchanged all of its existing warrants to purchase the Company&#146;s common stock, exercisable for an aggregate of 5,108,333 shares, for a new five-year warrant to purchase up to an aggregate of 8,000,000 shares of the Company&#146;s common stock at an exercise price of $0.30 per share.&#160; Also pursuant to the Exchange Agreement, Mr.&nbsp;Colatosti agreed to exchange all of his outstanding shares of Series&nbsp;D Convertible Preferred Stock, including all accrued and unpaid dividends thereon, and the 7% Convertible Promissory Note dated as of December&nbsp;28, 2009 issued by the Company to Mr.&nbsp;Colatosti in the original principal amount of $64,878 for a new non-convertible 7% Secured Promissory Note in the original principal amount of $350,804 (the &#147;Colatosti Note&#148;).</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The principal and interest, which will accrue at a rate of seven percent per year, under the Shaar Note is scheduled to be repaid by the Company in cash in five installments, as follows: (i)&nbsp;$300,000 on April&nbsp;30, 2011, (ii)&nbsp;$300,000 on July&nbsp;31, 2011, (iii)&nbsp;$300,000 on October&nbsp;31, 2011, (iv)&nbsp;$1,400,000 on December&nbsp;31, 2011 and (v)&nbsp;$857,759 on December&nbsp;31, 2012.&#160; The principal and interest, which will also accrue at a rate of seven percent per year, under the Colatosti Note is scheduled to be repaid by the Company in cash on December&nbsp;31, 2012.&#160; The Company&#146;s obligations under the Shaar Note and the Colatosti Note are secured by substantially all of the Company&#146;s assets and Mr.&nbsp;Colatosti&#146;s right of payment under the Colatosi Note is subordinated to the rights of Shaar under the Shaar Note.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the Exchange Agreement, the Company made a cash payment to Shaar in the amount of $500,000 at the closing of the exchange and also agreed to pay approximately $125,000 to Shaar on January&nbsp;31, 2011 in full satisfaction of the Company&#146;s obligations to Shaar</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2<a name="PB_2_224908_7056"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\106200\11-1932-1\task4420356\1932-1-ba.htm',USER='106200',CD='Jan  7 02:19 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">for all accrued and unpaid dividends with respect to the Company&#146;s Series&nbsp;B Convertible Preferred Stock and Series&nbsp;C Convertible Preferred Stock formerly held by Shaar.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 7.01</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Regulation FD Disclosure</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On January&nbsp;6, 2011, the Company issued a press release related to the above-described transactions. &nbsp;A copy of such press release is attached as Exhibit&nbsp;99.1 to this Current Report on Form&nbsp;8-K and is incorporated herein by reference in its entirety.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The information, including the exhibit attached hereto, in this Item 7.01 shall not be deemed &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 9.01.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Financial Statements, Pro Forma Financial Information and Exhibits.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Exhibits</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Press Release, dated </font><font size="2" style="font-size:10.0pt;">January&nbsp;6, 2011, issued by the Company.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3<a name="PB_3_224932_5335"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\106200\11-1932-1\task4420356\1932-1-ba.htm',USER='106200',CD='Jan  7 02:19 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>  </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-KEY INTERNATIONAL,&nbsp;INC.</font></p>  </td>  </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date: January&nbsp;6, 2011</font></p>  </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>  </td>  </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>  </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>  </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.24%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Cecilia C. Welch</font></p>  </td>  </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>  </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>  </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.24%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cecilia C. Welch</font></p>  </td>  </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>  </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>  </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.24%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief Financial Officer</font></p>  </td>  </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4<a name="PB_4_225126_5796"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\106200\11-1932-1\task4420356\1932-1-ba.htm',USER='106200',CD='Jan  7 02:19 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT&nbsp;INDEX</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.84%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit&nbsp;No.</font></b></p>  </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.32%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>  </td>
<td width="86%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:86.84%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description</font></b></p>  </td>  </tr>
<tr>
<td width="10%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:10.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>  </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>  </td>
<td width="86%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:86.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>  </td>  </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>  </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.32%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>  </td>
<td width="86%" valign="top" style="padding:0in 0in 0in 0in;width:86.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press Release, dated January&nbsp;6, 2011, issued by the Company.</font></p>  </td>  </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5<a name="PB_5_225155_2897"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='5',FILE='C:\JMS\106200\11-1932-1\task4420356\1932-1-ba.htm',USER='106200',CD='Jan  7 02:19 2011' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a11-1932_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>


<html>
<head>


  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.1</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="53%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:53.92%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="192" height="144" src="g19321mmi001.jpg"></font></p>  </td>
<td width="20%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:20.6%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company Contact:</font></p>  </td>
<td width="25%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:25.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key International,&nbsp;Inc.<br>  </font></u><font size="2" style="font-size:10.0pt;">Bud Yanak<br> 732-359-1100</font></p>  </td>  </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BIO-key Takes Steps to Improve Its Balance Sheet</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">&nbsp;Debt and Warrants Exchanged and Preferred Stock Eliminated</font></i></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WALL, NJ, January&nbsp;6, 2011 (GLOBE NEWSWIRE) &#151; BIO-key International,&nbsp;Inc. (OTC Bulletin Board: BKYI.OB ), a leader in finger-based biometric identification solutions announced today that it has successfully completed a series of transactions which will improve the Company&#146;s balance sheet on a go-forward basis.&nbsp; Specifically, the Company has restructured its outstanding convertible notes, redeemable convertible preferred stock and note receivable.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Effective as of December&nbsp;30, 2010, BIO-key restructured its $4.0 million note receivable from InterAct911 Mobile Systems, a wholly-owned subsidiary of InterAct911 Corporation.&#160; Under the original terms of the note, the first scheduled principal repayment, equal to approximately $1.3 million, was due to be paid to BIO-key in December&nbsp;2010.&#160; In connection with the restructuring, BIO-key deferred $834,000 of this first payment into three equal payments due over the course of the first three quarters of 2011.&nbsp; In exchange for this deferral,&nbsp;Interact911 made a cash principal repayment of $500,000, agreed to increase the interest rate on the deferred amount from six percent to twelve percent, and agreed to have the owner of its corporate parent, Silkroad Equity LLC, forfeit all of the 8 million warrants previously granted to it.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In a separate transaction, effective as of December&nbsp;31, 2010, BIO-key and The Shaar Fund,&nbsp;Ltd., the primary holder of shares of the Company&#146;s Series&nbsp;D Convertible Preferred Stock and Convertible Promissory Note, agreed to restructure their existing arrangements. Specifically, The Shaar Fund agreed to exchange such Preferred Stock and Convertible Note for a new non-convertible secured promissory note with repayment terms that coincide with the note receivable repayment terms from InterAct911.&nbsp; As such, the Company expects that future cash flow generated by the Interact911 note receivable will offset future cash payments owed to The Shaar Fund.&#160; As part of this agreement, the Company has eliminated all of its remaining outstanding preferred stock.&#160; The Company also agreed to exchange all existing 5.1 million warrants previously issued by the Company to The Shaar Fund for a new f
ive-year warrant to allow the Shaar Fund to purchase up to an aggregate of 8 million shares of the Company&#146;s common stock at an exercise price of $0.30 per share.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Discussing the restructuring, Mike DePasquale, CEO of BIO-key International, commented, &#147;We are very pleased to have concluded these series of agreements as the impact to our Company&#146;s balance sheet is notable.&nbsp; We have removed all of the potential dilutive effects from the Redeemable Convertible Preferred Stock and Convertible Notes, reduced the potential dilutive effects of our warrants and have structured future payments and receivables from these </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106200\11-1932-1\task4420356\1932-1-mm.htm',USER='106200',CD='Jan  7 02:21 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">transactions to coincide with one another.&nbsp; The net effect will offset our interest expense against interest income.&nbsp; We also made progress in our operations during the 2010 fourth quarter, which we will share with investors as part of our 2010 annual report.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Additional details on the relevant prior transactions can be obtained by viewing the Company&#146;s Form&nbsp;10-K and Form&nbsp;10-Q reports on file with the Securities and Exchange Commission.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About BIO-key</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key International,&nbsp;Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers.&nbsp;BIO-key&#146;s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world&#146;s largest identification deployments to improve security, guarantee identity, and help reduce identity theft.&nbsp;&nbsp;BIO-key&#146;s technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BIO-key Safe Harbor Statement</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certain statements contained in this press release may be construed as &#147;forward-looking statements&#148; as defined in the Private Securities Litigation Reform Act of 1995 (the &#147;Act&#148;).&nbsp; The words &#147;estimate,&#148; &#147;project,&#148; &#147;intends,&#148; &#147;expects,&#148; &#147;anticipates,&#148; &#147;believes&#148; and similar expressions are intended to identify forward-looking statements.&nbsp; Such forward-looking statements are made based on management&#146;s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the &#147;safe-harbor&#148; provisions of the Act.&nbsp; These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements.&nbsp; These risks and uncertainties include, without limitation, our history of losses and limi
ted revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel.&nbsp; For a more complete description of these and other risk factors that may affect the future performance of BIO-key International,&nbsp;Inc., see &#147;Risk Factors&#148; in the Company&#146;s Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2009 and its other filings with the Securities and Exchange Commission.&nbsp; Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.&nbsp; The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106200\11-1932-1\task4420356\1932-1-mm.htm',USER='106200',CD='Jan  7 02:21 2011' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g19321mmi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g19321mmi001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`"0`,`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V7-&:**`#
M-&:*0D`$DX`ZT`+FC-<?K_Q'TG26:"T/V^Y7C;&<(I]V_P`*\^U?QUK^L%E>
M[-M"?^65O\@Q[GJ:PGB(1TW.^AE]:KK:R\SV'4->TG2A_IVH6\!_NLXW?EUK
MGKOXH^'K<D0?:;HC_GG'@'\3BO'2<DLQR3U)/-:.G>']8U;_`(\=.GF7^_MP
MOYGBN9XF<G[J/2CE="FKU9?H=W-\78O^6&C2'WDF`_D*@_X6[<?]`:/_`+_G
M_"L^S^%>NS@&YGM;4'L6+G]./UK6A^$*8_?ZT^?2.`#^9IIXADM9;#1Z_>,C
M^+S9_>Z*,?[$_P#B*T;7XLZ/(0+FRNX/<`./T-0CX1Z?CG5;LG_<6H)OA#'C
M]QK3@^DD`/\`(U2^L(R?]FR[K[SJK#QKX=U(A8-3B5S_``2_NS^M;BNKJ&4A
ME/0@Y!KR2\^%.M1`FWN;2Y'H24/Z\5F+%XP\(/O5+RUC4\X_>1'Z]15^VG'X
MXF;P5"I_!J+T?]?H>WYHS7G6@_%2&8K#K<`A)X^T0C*_BO4?AFN_M;J"]MTN
M+:9)HG&5=&R#6\*D9[,X*V'J47::)LT9HHJS`,T9HHH`,T9HHH`,T44"@`HH
MK+\0:]:>'M,>\NVR>D<8/S2-Z"DVDKLJ,7)J,=R76-:L-#L6N[^81H.%'5G/
MH!W->1>)O'6I>(&:",M:6/:%&Y<?[1[_`$Z5DZWKE]K^H->7LF3T2,?=C7T`
MJC%%)/*D,,;22.=JHHR6/H*\ZK7<W:.Q])A,!"BN>IK+\$,X`]!72^'?`NK>
M(`LVW[):'_EO*/O#_97O_*NP\)?#F"R6.^UI%GN?O+;GE(OK_>/Z5WH``P.`
M.@JZ6&OK,PQ6:6?+1^__`".:T7P%H6C!7^S?:[@?\M;CYN?8=!72@!0```!T
M`I:*[8Q459(\.=2=1WF[A1115$!14%W>VMA`9[NXC@B7J\C!17)ZA\4=!M&*
M6RSWK#O&NU?S-1*<8[LUIT:E7X(W.SI#R,=C7G'_``MB:=O]$T"24?\`74L?
MT6K$?Q.N(^;SPU>1K_>0G^JBH]O#N=#P&(6\?Q1NZWX%T/6@SM;"VN#_`,MK
M?"G/N.AKB9-+\3_#RY:[LG^V:>3F3:"4(_VE_A/N*[/2_B#X>U1Q$+LVLQX\
MNY&SGZ]/UKI/ED7LRL/J"*3A"?O1>OD5&O6H>Y55UV?Z&/X;\46'B6S\ZU;9
M*@_>P,?F0_U'O6U7!^(?!MQIEY_;_A;]Q=1$M):I]UQWVC_V7\JZ/PQXBM_$
MFF+<QCRYD.V>$]8V_P`/2JA)WY9;F5:E"WM*7P_BO4V:***U.4****`"@44"
M@"*YN8;2VDN)W$<42EW8]`!7A7BCQ%/XDU=[I\K`F5@C/\"_XGJ:[/XH^(0L
M*:%;O\SD/<X[#JJ_CU_"O,Z\_$U+OE1]#E>&Y8^VEN]O04`D@`$D\`#O7K_@
M3P8FBVZZC?QAM0E7@'_E@I[#W]3^%<S\,_#:ZA?MJ]U'N@M6Q$".&D]?P_F:
M]&O?$>AZ:=M[K%E;L.JR3J#^6:O#4OMLRS/%N_L8/U_R-+%+619^+?#FH2B&
MSURPFD/`1;A<GZ#-:Y..M=IX8452_MG2@<'4[/\`[_K_`(U/;WEK=AC:W,,X
M7[WE2!L?E0!-7*^,?&T'AN/[-`JSZA(N5C)^6,?WF_PKJ37D.M>&[8>*9[C6
M/$NFQ6DLQD>1[E1+MS]W;V../2LJKFE[AUX2-&4[UG9+\2EI^D^(?'M^;B>=
MFB5OFN)?]6GLJ^OL*]"T?X>:#I:JTMO]NG'62XY&?9>@K5T._P!"FLX[71+V
MSFAB7"I;RJV!]`:U:F%&,=7JRZ^.J5/=A[L>R&1010($AB2-1T5%`'Z4^BBM
MSA,W4?#VD:M&4OM.@FS_`!%`&'XCFL-='U7PF?.T:674--',FGS-ET'K&W]#
M74W-U;V<#3W4\<$2_>DE<*H_$TL$\-U`D]O*DL4@W)(C!E8>H(J'!/7J:QK2
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M+U#[-9V2C[=$C%&F=B.<CJ,D\5YQ\//",7C7Q$]A<W3P0Q0M-(R`%FP0,#/U
MKVWXN#_BVVI_6/\`]&+7E?P9U.RT?Q'J%_J-REM;16#;Y'/`RZ`5Z*5E9'S<
MI.3<GNS0\?\`PBMO#6@R:SI-[/-';D>=%/@D*3C<"`.Y'%:/P>\5W>M+>>$M
M6FDN('MF,#LQWJO1DW=<8.1Z4_XE_%+1-5\-SZ)HDKW4ET5$DVPJB*"#QGDD
MXI/@EX/OK6[F\27T+P1/"8K57&#)D@EL>G&!ZYIDGG_Q"\.6?A7Q;/I5C)*\
M"(CJ92"PW#.,BO8OA3X6TS0/#$/B!9I?/O[4/.TCX1%&3P/;U->9_&C_`)*-
M=?\`7"+_`-!KM-:U233/V?=/$3;7NX([?(]&)+?H"/QH`Y#QQ\2=6\7:J=,T
M>2:#3C)Y<,4)(>X.<`MCGGLM='HGP&\ZQ2;6]5DAN'&3#;H#L]BQZGZ"N:^"
MVEIJ'CV.>5`RV4#S#/\`>X4?^A9_"OHR@#YX\:?"[5/!,0UG3+Z2ZM(F&Z5`
M8Y8#V)P>F>XKM/A1\2KC79/[!UN7?>JA:WN#UF`ZJW^T!SGO7I6HV46I:=<V
M,ZAHKB)HV!]",5\GZ==S^'O$L%S&Q6:QN@<C_9;!'X\T`?7-%-1Q)&KKT8`B
MG4`?//QDTS5=.\1I+?:M)>V]Z7DMXF)`@4'[N.G&>HKUGX6DGX;Z/G_GFW_H
M;5Y]^T!_R$M%_P"N,O\`Z$M=!X9\;:5X,^&/A^74UN&%RLBH((]W1SG.2`.M
M`'H]Y;"[MFA)VY((;T(.0?S%3UPVB?%WPYKVL6^EVD-^L]RVU"\(VY]\,<5N
M^)_&&B^$K19]5N=K29\N&,;I)/H/ZGB@!]S%]G\565VO`NH'MY/<K\Z_^S5L
MUY-)\<?#UU=VYETK4$2&7>KJ4)Z$<C/H:Z+4/BYX5T^QM+M9KB[CNP=OD1Y*
M$8R&!(P>>E)*Q4G=([>BN`T[XS>&-3U*WL(8=062YD6-"T(P"3@9PQ-:'BCX
MF:%X2U0:;J,=X\YC$G[F(%0#TY)%,DZ^@5Q^B_$W0M>M+F>RCNP;8J&22(*6
MR">#G'`4D^E=#I6KPZJCF-&C=/O(V#QDC((ZC((^H-`%^BBB@#C/BW_R3;5/
M^V?_`*,6O*/@]HUAK^NZEINI0">VEL3N0DCD.A!!'0BO3?C'J=E:^!+NQFN8
MTN;O9Y,1/S/AU)P/05YW\"IXXO&ES&\BJTMDP0$XW'<IP/PH`Z+QM\&M)M-!
MN=2T!IX9[2,RM#(^]9%')QGD'%8'PC\=ZA8Z_;:!>W+SV%V?+B61LF%_X=I/
M8],>]>N>.M>L]`\)7\]U*JO+`\4,9/,CL"``/QKP#X::9/JGC[2TA0LL$PGD
M8?PJO.3^@_&@#2^-'_)1KK_KA%_Z#72^+('E^`6A2*,B$PLWL"&'\R*YKXT?
M\E&NO^N$7_H->K:!HL7B/X-V6DRD*+FP"JQ_A;JI_`@4`>=_`>=(_&%Y"QPT
MMDVW\&4U[[7RMHE_?^`?&T5Q=6[I/8S%)X3P64\,!]0<@_2OIC1M?TO7[%+S
M3+V*XB<9^5AN7V8=0:`-`D*"Q.`.2:^0M0;[;KMT\7/GW+E,=]S''\Z^@/B9
M\0+#P_H=SIUG=1S:I=1F-8XV!,(/!9L=..@]:\M^$WA&7Q%XIBO9HB=/TYA+
M*Q'#..53\^3["@#TK7_BUIOA+5#H<^FW5Q+:Q()'1E`W%0<<_6LS_A?^E?\`
M0#O/^_JUWVI^#/#>LWK7NHZ/;7-PP`:1UY('3-5/^%;^#?\`H7K/_OD_XT`>
M4?&35X=>M_#6JVZ.D5U:22*K]5RPX-9,GBN;6O">A>!M/V0JS!+F:?`!<R$J
M`>RC()/>M_X[6MO8W6@VEK"D,$-M(L<:#`4`C`%<WJO@:2+P!I7BNP5W21"+
MQ,YV'>0''MP`?2@#WGPEX/TSPCI,=I:1(TP&9KEE&^1NYSV'H*^?]3N[GQW\
M20D\K;;R]$$8S_JXMV`!^'/UKU?X3>/O^$BTT:+J<N=2M4^1V/,\8[_[P[_G
MZUXY>6C^&?'4MM>F6%;:[*N\?#",G[R^^TY%`'I/Q,UKP5IOAB3PQIMI;3WJ
M;5C^SH,6Q!Y+/Z]L=>>:I?"[P%J&H:-J_P#;%JT&G:C;B.!95^8R=I%!Y&/7
MOFNO\&_#3PIHMO'JZSIJ[L/,CNYL>6H[$+T'U/Z5NZ3X\T#7/$4^AZ=<M<7$
M"%S(JYC8#`.UN^,B@#P_X?:@W@[XD):ZE&J@RM9S[P/D).`P/;Y@.?0UVWQM
MO?M]UH_AFSC22\N91(?E!89.U!GJ,DD_A6)\<?#?V#7;?7X$VQ7PV2D=I5'!
M_%<?D:E^%T5[XQ\=2^)=782_V;`H#D8&_;M7]`3]:`/48/!]G:^&K31K;;#]
MF0#>$R)#MPVX=]V3FM#1]'&EJY:17=@%547:D:`DA5&2<98]37-:G\4=(LKM
MK>VMY[T(<-+&0JD^Q/6MGPUXOTWQ-YB6OF13QC<\,HPP'J,=16:J0;LF=$L-
M6A#GE%V-ZBBBM#G.9\8^`])\:P1"_,L-Q`"(IXC\R@]00>"*\YN/@'?Q3;]/
M\00D`Y4RPLC#\037ME9GB21X?#&J2Q.R2)9RLK*<%2$."#0!Y1#\"=5NIU?5
M?$<;*.I1&D;'L6(KT3P]X$TGPQHUQ8:698IKJ,I+>D@S$XP"#VQG(`KAM1U7
MQ#%I_@>YTJYFFN1I\ES-"TC'[4$1&96_O$C.,UO>%[V'QKJ'B;9J%W]@N#:M
M"89V1H08\D*1]TY&#B@#GY_@))<3---XHDE=CDO);%F/U)>NO\!^`9?!1N`V
MMSW\<RA5A9=L<>#G(&3S69\/M),E[K%[-JFJ3OIVI3VL*37CNFP#`W*>IYZU
M@>#8KO4[>RN;JT\5W+O<'==Q:ABWP)",[2V<#'/'8T`=]XM\`:'XQC#7T317
M2#"74/#@>A[,/8UYO/\``7589V-AK]N4/>1&1L?AFM#Q3J,4'C?Q`VIR^(FL
M[2*!D_LN=D2#*\E^0!DXY^M6-6?Q4GP\\-1G4G35[G4$6.839+*0Y0.R\-QM
MSVH`J:1\!(DG636=9,R`Y,5M'MW?\"/^%>JZ5I-AHFGQV&FVR6UM%]U$'ZD]
MS[FN(\*>*)?$?CI',DD.S1RMU9ECB&X67:V5]??T-85IXY)^("ZP^MQMIUU?
M/IPL/.YCC``2;;GC+@\^E`'L%%>;>)/#RKX\T6TCU?6(X=6>X>X1+]U`VKN`
M4?PC)Z5=FN[C2/B#):Q7%Q-;V?ATRK#)*6#LK\$^K$#KUH`RO$GP<N?$>MW&
MHS^)YV65RT<<L._RE)SM'S=!]*W?!7P^;PK97ME>:O)JEG=)L^S21[8T'.<`
MD]<USL6GW]Q\/6\;-XDU)=7,#7@87!$"X)_=^7TVX&*7Q#XDUV+Q#H&L6'F-
M&FCB^O+)6.V6/<-^%Z9`;(^E`$,GP)6'4VN]+\1S6:ART($)+QCTW!A^==/X
MG^&6F>*-.M4O+F8:C;0K$-0`!>7`_C'1O7^M5?"WBB'[!XLUV2\>XL;>\>6`
MLY($?EJ0J^G)Z>IK*^&GB6=]??3[_6DU%]6MA?1A9M_V>3)W1=>,+@X]J`,A
M/@3JRYMSXFC6U)Y58GY'^[G%>B>#?`>D>"[9Q9!IKJ48EN9<;F'H/0>U0>!;
MNZN[CQ&+FXEF$.L31Q^8Q.Q0!A1Z#VKK"<`D#)]*`/-/CAK5C:^%8](E19;N
M\D5XAWC53R_]/Q-9ME;GP9\(K>W_`-7?ZR?,D[,%89_1<#\:R)_!/B_Q;\0!
MJ/B/36M;'S@97:12D<*G(5>?3^9-.\::^-?UQG@/^AVP\JW`Z8'4_C_+%85Y
M\L/4[\OH>UK)O9:G/UW'PH@=_$ES.`=D=H58^Y9<#]#^5</TKVKX>Z&VC^'$
M>9-MQ>'SG!'('\(_+^=<6'CS33['MYE54*#75Z'4T445ZA\J%07UG'J%A<64
MQ817$31/M.#AA@X_.IZ*`,.U\):=9SZ/-$T^[1H&@MLN,%64*=W')P*=H?A7
M3/#EWJ%SIJ/&=0E$LL9;Y5(S]T=AR:VJ0C-`',^$GT19M7M],DN!/)>23W45
MP,.KMP2!_=XJO8_#JSTU$BLM>UV""-]ZPQWN$Y.2,8Z$U'XO\/WD-XGB70"4
MU"W'[Z-1_KD^G<X[=Q]*T?"WC"Q\26X4$07J#][;L>?JOJ/Y5E&>O++<Z9T4
MX>TIZKKY%;55T;P[JU]JE_:WDL>L1I%=2!/,A15!4`@<C(--T?PWX=N='TZT
MT_4IKNTTZ[%W;`3ABC#.%/&=O)X-=6Z+(A1U#*PP5(R"*Y74OASHMY*;BS,V
MF7!.=]JVT9_W?\,53YEJM28*E)6E=/ON7?\`A#-*37-1UF`S6]WJ5N8)VB8`
M8.,L!CAN!S44G@'P[)X;70?L2K`L803*JB88.=V_'7-8<G@GQ;;_`"V7BZ5D
M'02,X/\`,U5E\">,+SY;OQ(&7OF:0_IQ4.I+^4V6'I/_`)>K[F;VO3>&],OM
M,U+4M2=KO24=8$60,\FY0IW*.IP/:L*+QIX=NO%(UB'3]4FOY+;[(L2JK*R;
MMWW<]<U)8_"2W5P^H:I)+ZK"FW/XG)KLM(\.Z5H4>W3[-(F(P9#R[?5CS27M
M9/LBI+"4XV5Y/[D<Y!\-]'N(%#2:K;:?*_G/I#76(`V<X*CMGL#BNC;P_8MK
ML.L88306K6B1@CR_+)!QC'M6G16YP'*1?#G0H-&O-(A-S'97MT+F6)9!@D$'
M8./N\#BM"\\):/=7MA>1VRVD]A-YL3VJK&3Q@JV!R".U;=%`'*-\/K-;V[NK
M76M:LS>3M/+';7>Q"YZG&*ZE1M4+DG`QD]30[K&A=V"JHR6)P`*\V\8_$8.L
MFG:%)P?EDNQ_)/\`'\JB=2,%=F]##SKRY8(?\1/&2A)-"TV7+'Y;J53T']P>
M_K^5>:4O?/<UM>&/#%WXEO\`RH@8[:,CSIR.%'H/4^U>9*4JLCZBE3I82EOH
MMV:/@'PLVNZH+NY3_0;5@6R.)'[+_4U[.!@55TW3K72K"*RLXA'#$,*!_,^I
M-6A7HTJ:IQL?-XO$O$5.;IT"BBBM3D"BBB@`HHHH`*X?Q9X#-W<'5]"?[+J"
M'>R(VT2'U![-^AKN**B4%)69K2K3I2YH,\TT;XDW6G3G3_$UI(LD9VM,J8=?
M]Y>_U%=_IVK6&K0":PNXKA/]ALD?4=1537?#&E^(8=E];@R`829.'3Z'^AKS
MC5/AYKVASFZT>=[I%Y#0MLE7\._X5BW4I^:.U1PV(V?)+\#UZBO&;3XA^)]*
MD\B[=;@IP4NHL/\`F,&MZU^+J8`O-'<'N89@1^1%-8BF]]!3RW$1V5_1GI%%
M<1'\5M"8?O+:]C/_`%S4_P!:>?BIX=`X2]/_`&Q'^-7[:GW,/J>(_D9VE%<!
M/\6]-0'[/IEU*>V]E0?UK&O?BOJLP*V5C;VP[,Y,A_H*EXBFNII'+\3+[-CU
M<D*"20`.I-<SKGC_`$31@T:S?;+D?\LH#G!]VZ"O)]3\2:SK&1?:C-(A_P"6
M8.U/R'%98'(4#D]`*PGBOY4>A1RE+6K+[C?\1>,M5\1$QS2>1:YXMXCA3_O'
M^*L#I70Z-X&U[62K):FU@/\`RVN/E&/8=37HOA_X>:3HQ6>X'VZZ7D/*ORJ?
M9?\`'-91I5*KNSKJ8O#86/)#[D</X6\`7VN,ES>A[2QZ[B,/*/\`9'8>YKUO
M3].M-+LH[.RA6&&,8"K_`#/J?>K(I:[J=*--:'@XG%U,0_>V[!0**!6IR!12
MT4`)12T4`)12T4`)12T4`)1BEHH`IW^DZ?J<>R^LX;A?^FB`D?0]:YB^^%V@
M7)+6YN+-C_SSDW+^39KLZ*B4(RW1M3KU:?P2:/,;CX12@G[+K"D=A+#C]0:J
MGX2ZMGC4K,CZ/_A7K%%9O#TWT.I9EB5]K\$>3_\`"I=7_P"@C9?D_P#A4T'P
MBO"?](U>%1_TSA)_F17J5%+ZM3[`\RQ+Z_@CA;/X4:/"0;N[NKHCL"$!_+G]
M:Z73?#6C:3@V6G01,/X]NYOS/-:M%:QIPCLCFJ8FM4^*38F**6BK,!**6B@!
'**6B@#__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
